Member Article

Further expansion for North East firm

A NORTH EAST based Pharmaceuticals Company has announced that one of its subsidiary firms is set to create new jobs.

R5 Pharmaceuticals based in Nottingham, which was acquired by Newcastle’s Aesica in June 2010, sees the expansion as strategically essential for the company, following a period of increased demand from its client base.

The expansion will see a new analytical chemistry laboratory built this spring.

Paul Titley, Managing Director, R5 Pharmaceuticals said: “This is an exciting development for R5 and demonstrates our commitment to evolving and enhancing our service offering to meet market demands.

“That we are set to double the size of our site and create new facilities, which will enable us to introduce new services to our current provision, is testament to the dedication and expertise of the entire team.”

Aesica is one of the UK’s fastest growing companies and is currently undergoing a period of significant and rapid expansion both in the UK and Europe, as well as across America.

The R5 expansion follows Aesica’s recent announcement in December 2010 that it had acquired three manufacturing sites in Europe, almost doubling its workforce.

This was posted in Bdaily's Members' News section by Ruth Mitchell .